Biocon Biologics said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July...
Continue Reading
Foraying into the child nutrition segment, drug maker Dr. Reddy’s Laboratories launched CeleHealth Kidz Immuno Plus Gummies in the Indian market on other day. The...
Continue Reading
Aurobindo Pharma subsidiary CuraTeQ Biologics has entered into an exclusive license agreement with U.S. firm BioFactura Inc to commercialise BFI-751, a proposed biosimilar to recombinant...
Continue Reading
Pharmaceutical company, Dr Reddy’s Laboratories, announced that it is entering into the trade generics business in India with the launch of its new division, ‘RGenX’....
Continue Reading
Granules India Limited, a pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA) Pre-Approval Inspection (PAI) and GMP audit for their Unit...
Continue Reading
Aurobindo Pharma Limited (along with its subsidiaries together referred to as “Aurobindo”) announced that the breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin),...
Continue Reading
Aurobindo Pharma said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and...
Continue Reading
Sun Pharmaceutical’s subsidiary, Sun Pharma Canada Inc. has received Health Canada’s approval for ABSORICA LD, an oral drug used to treat severe acne in patients...
Continue Reading
Nova IVF Fertility, one of the largest chains of infertility treatment clinics in India, has ambitious plans to expand its network to 100 centers within...
Continue Reading